Back to Top

"One of today's leaders in investor relations and shareholder services"

Tag Archives: CBD

Medical Marijuana, Inc. Subsidiary HempMeds® Sponsors International Medical Cannabis Expo in Colombia

SAN DIEGO, Nov. 28, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the U.S., announced today that subsidiary HempMeds® was a Gold Sponsor of EXPO MEDE Weed, the second International Fair of Medical Cannabis, which took place in Medellín, Colombia on November 24-27, 2017.

This conference is organized annually to discuss the legality of medical cannabis globally. Currently in Colombia, non-psychotropic Cannabis (Hemp) is legal to grow if it contains less than 1% THC.

At the conference, executives from the Medical Marijuana, Inc. portfolio of companies spoke to hundreds of patients and doctors at the event about CBD and shared stories of previous international successes in Mexico, Brazil and Paraguay. Speakers included Dr. Stuart Titus, CEO of Medical Marijuana, Inc., and Raul Elizalde, President of HempMeds® Mexico.

“We are proud to sponsor this global event and speak with an international audience about our products …

Continue Reading

Posted in Client News| Tagged , |

Medical Marijuana, Inc. Subsidiary Kannaway® Announces New Pure Gold Zero-THC Hemp CBD Oil

SAN DIEGO, Nov. 6, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA), announced today that subsidiary Kannaway, LLC, the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products, has introduced Kannaway® Pure Gold, a full-spectrum hemp oil that provides all the benefits of hemp without the presence of THC.

Kannaway® Pure Gold is ideal for anyone who is subject to drug tests, including active and retired military, competing athletes, first-responders, or anyone concerned about THC in their daily CBD supplement. Starting with the same high-quality hemp oil used in all Kannaway products, new Kannaway® Pure Gold Liquid has been filtered down to include non-existent levels of THC to create the highest quality possible cannabinoid-dense CBD oil product.  

“We are very glad to be able to expand our customer base by offering the Kannaway® Pure Gold high-quality CBD oil to those who want to incorporate CBD into their lives without the presence of …

Continue Reading

Posted in Client News| Tagged , |
HempMeds® Brazil

HempMeds Brazil Scores Key Legal Victory and Gains Notoriety

HempMeds® Brazil

Medical Marijuana Inc. (OTC MJNA) has received recognition over the past year for its innovative products and successful marketing, which have made it a forerunner in the field of medicinal marijuana. The company and its subsidiary, Kannaway, accomplished record sales over the course of the past year. Now, another of Medical Marijuana Inc.’s subsidiaries, HempMeds®, is proving itself as a revolutionary as well, reforming the traditional views on marijuana in Brazil.

Who is HempMeds® Brazil?

HempMeds® is a subsidiary of Medical Marijuana Inc., which is a company that focuses on cannabis and hemp products. HempMeds® Brazil is the first company to gain legal approval to ship cannabis-related products into Brazil. All three products currently manufactured by HempMeds® Brazil are subsidized under Brazil’s health care system through the government. Their products are designed to treat conditions like epilepsy and Parkinson’s as well as chronic pain. As of now, the company …

Continue Reading

Posted in Articles| Tagged , , , , |

Medical Marijuana, Inc. Announces Prominent Coverage on Mexican News Station About Benefits of CBD and Global CBD Policy

SAN DIEGO, Nov. 2, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that Raúl Elizalde, General Manager of subsidiary HempMeds® Mexico, was recently interviewed on Azteca TV Mexico, resulting in notable media coverage of his upcoming speaking engagement at the World Health Organization Drug Scheduling Convention on Psychotropic Substances on November 6, 2017.

According to the interview, Elizalde explained that “The World Health Organization will address cannabidiol along with a list of other substances that they are analyzing to know if they need to be updated and scheduled as psychoactive substances. Cannabidiol is not psychoactive and we wonder how cannabidiol ended up in a list of substances with some synthetic ones like ketamine and vigabatrin.” He later went on to say that “part of what I’m going to do at the World Health Organization is to talk to …

Continue Reading

Posted in Client News| Tagged , |

MJNA Numbers Don’t Lie This is a Company on the Rise

Medical Marijuana, Inc. has earned its title as a leader in the medical marijuana industry. It’s pioneering the way for more acceptance of medicinal marijuana as well as deriving revolutionary products. Today, the company is yet again proving itself and standing stronger than ever with record sales for a month.

Who is Medical Marijuana, Inc.?

Medical Marijuana, Inc, is a premier hemp and cannabis industry leader. With innovative ideas from experts in the field, the company is continuing to develop unique products that benefit overall health and wellness. The company focuses on creating awareness about the cannabis industry. The company develops environmentally-friendly and sustainable products. Additionally, Medical Marijuana, Inc. increases shareholder value with each and every product they develop.

Medical Marijuana, Inc. touts about being a company of firsts. It’s the first publicly traded cannabis company ever in the United States. Moreover, it’s the first direct sales and network …

Continue Reading

Posted in Articles| Tagged , , , , |

MJNA Offers the Ideal Option for Athletes in Massive Recovery Market

Medical Marijuana, Inc. is a company that carved out a significant section of a highly competitive market in 2016 and 2017, and it stands to gain even more traction on the international market in the years to come. A major international move for the company promises to expand its market share and yield new growth opportunities in a global sphere.

Medical Marijuana Markets in the United States

It is estimated that the legal marijuana industry has a value of $7.1 billion in the United States alone. This figure is expected to see continued growth throughout the remainder of 2017 and well into 2018 as the American public and medical community become more aware of the benefits of CBD oil products. While this figure includes both legal recreational and medicinal use in the United States, medical marijuana products show unprecedented potential for market growth due to their versatile treatment indications.



Continue Reading
Posted in Articles| Tagged , , , |